PF-05212377
PF-05212377 Uses, Dosage, Side Effects, Food Interaction and all others data.
PF-05212377 is under investigation in clinical trial NCT01712074 (Study Evaluating Thesafety and Efficacy of PF-05212377 or Placebo in Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms on Donepezil).
| Trade Name | PF-05212377 |
| Generic | PF-05212377 |
| Type | |
| Formula | C18H20N4O2S |
| Weight | Average: 356.44 Monoisotopic: 356.130697074 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PF-05212377
